Long-term lithium treatment and survival from external causes including suicide [22]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 5, 2007, Pages 544-546

  Bocchetta, Alberto ^a   Fadda, Domenica ^a   Satta, Giannina ^a   Del Zompo, Maria ^a   Gessa, Gian Luigi ^a   Cocco, Pierluigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

BIPOLAR DISORDER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LETTER; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDE; SURVIVAL;

ANTIMANIC AGENTS; CAUSE OF DEATH; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LITHIUM COMPOUNDS; MALE; MENTAL DISORDERS; PATIENT COMPLIANCE; RISK ASSESSMENT; RISK FACTORS; SUICIDE; TREATMENT REFUSAL;

EID: 34548665715     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31814f4d94     Document Type: Letter

References (20)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. Oxford, England: Oxford University Press; 1990.
2. Norton B, Whalley LJ. Mortality of a lithium-treated population. Br J Psychiatry. 1984;145: 277-282.
3. Sharma R, Markar HR. Mortality in affective disorder. J Affect Disord. 1994;31:91-96.
4. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162:1805-1819.
5. Muller-Oerlinghausen B, Ahrens B, Grof E, et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand. 1992;86:218-222.
6. Wolf T, Muller-Oerlinghausen B, Ahrens B, et al. How to interpret findings on mortality of long-term lithium treated manic-depressive patients? Critique of different methodological approaches. J Affect Disord. 1996;39:127-132.
7. Coppen A, Farmer R. Suicide mortality in patients on lithium maintenance therapy. J Affect Disord. 1998;50:261-267.
8. Vestergaard P, Aagaard J. Five-year mortality in lithium-treated manic-depressive patients. J Affect Disord. 1991;21:33-38.
9. Brodersen A, Licht RW, Vestergaard P, et al. Sixteen-year mortality in patients with affective disorder commenced on lithium. Br J Psychiatry. 2000;176:429-433.
10. Ahrens B, Muller-Oerlinghausen B, Grof P. Length of lithium treatment needed to eliminate the high mortality of affective disorders. Br J Psychiatry. 1993;163(suppl 21): 27-29.
11. Muller-Oerlinghausen B, Wolf T, Ahrens B, et al. Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients. Acta Psychiatr Scand. 1994; 90:295-297.
12. Kessing LV, Sondergard L, Kvist K, et al. Suicide risk in patients treated with lithium. Arch Gen Psychiatry. 2005;62:860-866.
13. Bocchetta A. Mortality follow-up of patients since commencing lithium therapy. J Clin Psychopharmacol. 2005;25:197-199.
14. Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry. 1995;28:8-13.
15. Ahrens B, Muller-Oerlinghausen B, Schou M, et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord. 1995;33:67-75.
16. Kallner G, Lindelius R, Petterson U, et al. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiatry. 2000;33: 8-13.
17. Muller-Oerlinghausen B, Wolf T, Ahrens B, et al. Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-treated patients (IGSLI). Acta Psychiatr Scand. 1996;94:344-347.
18. Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a metaanalytic review. Bipolar Disord. 2006;8: 625-639.
19. Thies-Flechtner K, Muller-Oerlinghausen B, Seibert W, et al. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry. 1996; 29:103-107.
20. Goodwin FK, Fireman B, Simon GE, et al. Suicide risk in bipolar disorder during treatment with lithiumand divalproex. JAMA. 2003; 290:1467-1473.